Artelo Biosciences Stock Price on December 17, 2024
| ARTL Stock | USD 1.05 0.08 8.25% |
Below is the normalized historical share price chart for Artelo Biosciences extending back to November 14, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Artelo Biosciences stands at 1.05, as last reported on the 27th of December, with the highest price reaching 1.06 and the lowest price hitting 0.97 during the day.
If you're considering investing in Artelo Stock, it is important to understand the factors that can impact its price. As of now, Artelo Stock is relatively risky. Artelo Biosciences secures Sharpe Ratio (or Efficiency) of 0.0022, which signifies that the company had a 0.0022% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Artelo Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Artelo Biosciences' Mean Deviation of 3.23, standard deviation of 4.81, and Risk Adjusted Performance of 0.0081 to double-check if the risk estimate we provide is consistent with the expected return of 0.0108%.
At this time, Artelo Biosciences' Total Stockholder Equity is quite stable compared to the past year. Common Stock Total Equity is expected to rise to 6,281 this year, although the value of Capital Stock will most likely fall to 2,565. . The value of Price Earnings Ratio is estimated to slide to -0.78. The value of Price Book Value Ratio is estimated to slide to 0.46. Artelo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of November 2017 | 200 Day MA 1.2775 | 50 Day MA 1.1237 | Beta 1.35 |
Artelo |
Sharpe Ratio = 0.0022
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARTL |
Estimated Market Risk
| 4.93 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Artelo Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Artelo Biosciences by adding Artelo Biosciences to a well-diversified portfolio.
Price Book 0.5305 | Book Value 3.685 | Enterprise Value -1.4 M | Enterprise Value Ebitda 1.215 | Shares Float 3.2 M |
Related Headline
Vaccinex Headline on 17th of December 2024
Vaccinex Faces Nasdaq Delisting Amid Financial Struggles Sha... by gurufocus.com
Following breaching minimal listing criteria, Vaccinex will be delisted from Nasdaq, the firm said. As the company negotiates clinical trial
Artelo Biosciences Valuation on December 17, 2024
It is possible to determine the worth of Artelo Biosciences on a given historical date. On December 17, 2024 Artelo was worth 1.05 at the beginning of the trading date compared to the closed value of 1.02. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Artelo Biosciences stock. Still, in general, we apply an absolute valuation method to find Artelo Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Artelo Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Artelo Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 1.09 | 1.14 | 1.06 | 1.06 | 31,976 | |
12/17/2024 | 1.05 | 1.08 | 1.02 | 1.02 | 30,035 |
| 1.03 | 1.05 | 0.94 | 0.96 | 46,609 |
| Backtest Artelo Biosciences | | | Artelo Biosciences History | | | Artelo Biosciences Valuation | Previous | Next |
Artelo Biosciences Trading Date Momentum on December 17, 2024
| On December 18 2024 Artelo Biosciences was traded for 0.96 at the closing time. The top price for the day was 1.05 and the lowest listed price was 0.94 . The trading volume for the day was 46.6 K. The trading history from December 18, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.88% . The overall trading delta against the current closing price is 4.90% . |
Artelo Biosciences Fundamentals Correlations and Trends
By evaluating Artelo Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Artelo Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Artelo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Artelo Biosciences Stock history
Artelo Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Artelo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Artelo Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Artelo Biosciences stock prices may prove useful in developing a viable investing in Artelo Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.2 M | 3.3 M | |
| Net Loss | -6.7 M | -6.4 M |
Artelo Biosciences Quarterly Net Working Capital |
|
Artelo Biosciences Stock Technical Analysis
Artelo Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Artelo Biosciences Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Artelo Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Artelo Biosciences December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Artelo Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Artelo Biosciences shares will generate the highest return on investment. By undertsting and applying Artelo Biosciences stock market strength indicators, traders can identify Artelo Biosciences entry and exit signals to maximize returns
Artelo Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Artelo Biosciences' price direction in advance. Along with the technical and fundamental analysis of Artelo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Artelo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0081 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.87) | Return On Assets (0.54) | Return On Equity (0.89) |
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.